scholarly journals Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial

2017 ◽  
Vol 18 (3) ◽  
pp. 393-403 ◽  
Author(s):  
Corneel Coens ◽  
Stefan Suciu ◽  
Vanna Chiarion-Sileni ◽  
Jean-Jacques Grob ◽  
Reinhard Dummer ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Complete Resection ◽  
Health Related Quality ◽  
Phase 3 ◽  
Double Blind ◽  
Related Quality ◽  
Health Related ◽  
Stage Iii Melanoma ◽  
Secondary Outcomes

scholarly journals Health-Related Quality of Life as Measured by the 36-item Short Form Survey Among Adults with Acute Bacterial Skin and Skin Structure Infections Who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial

2021 ◽  
Author(s):  
Surya Chitra ◽  
Jordan Hinahara ◽  
Thomas F Goss ◽  
Kyle Gunter ◽  
Kenneth LaPensee
Keyword(s):  
Quality Of Life ◽  
Short Form ◽  
Oral Treatment ◽  
Health Related Quality ◽  
Phase 3 ◽  
Double Blind ◽  
Skin Structure ◽  
Related Quality ◽  
Health Related

Abstract This analysis of data from a Phase 3 study of adults with acute bacterial skin and skin structure infections showed that successful oral treatment with omadacycline (n=368) or linezolid (n=367) was associated with improvement in health-related quality of life.

Sign in / Sign up

Export Citation Format

Share Document